fourteen patients with adenocarcinoma of the gastrointestinal tract and pancreas treated with mitomycin c ( mmc ) and 5-fluorouracil ( 5-fu ) had renal impairment 6-11 months from the beginning of mmc therapy .
C0001418
adenocarcinoma
C0002475
mmc